Brittenham Marissa
SEC CIK 1908044 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SGRY | Surgery Partners, Inc. | Chief Strategy Off | 94.2K | — | $757.0K | 13 | 2022-02-01 | 2026-03-13 |
Most active insiders at SGRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Evans Jason Eric | CEO | — | $412.4K |
| 2 | Doherty David T | CFO | — | $312.5K |
| 3 | DeLuca Teresa | Dir | $304.7K | — |
| 4 | Baldock Jennifer | Chief Admin, Dev Off | — | $214.5K |
| 5 | Brittenham Marissa | Chief Strategy Off | — | $166.2K |
| 6 | Burkhalter Danielle | CHRO | — | $149.7K |
| 7 | Webb William Trenton | American Group Pres | — | $28.7K |
| 8 | Oppenheimer Justin Robert | COO, National Group Pres | — | — |
| 9 | Deane John A | Dir | — | — |
| 10 | Forese Laura L | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | 2026-03-13 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | S - Sale | $12.54 | -3,657 | 94.2K | -4% | -$45.9K | |
| 2026-03-09 | 2026-03-06 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | S - Sale | $13.70 | -8,785 | 54.6K | -14% | -$120.4K | |
| M | 2026-03-09 | 2026-03-05 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | A - Grant | $14.11 | +43.2K | 97.9K | +79% | +$610.0K |
| 2025-03-13 | 2025-03-10 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | S - Sale | $24.09 | -3,156 | 63.4K | -5% | -$76.0K | |
| M | 2025-03-06 | 2025-03-04 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | A - Grant | $23.80 | +16.4K | 66.6K | +33% | +$390.0K |
| 2025-02-10 | 2025-02-07 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | S - Sale | $25.61 | -14.7K | 50.2K | -23% | -$376.5K | |
| 2025-02-04 | 2025-01-31 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | A - Grant | $0.00 | +25.1K | 64.9K | +63% | $0 | |
| 2024-03-06 | 2024-03-04 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | S - Sale | $30.17 | -1,284 | 39.8K | -3% | -$38.7K | |
| M | 2024-03-01 | 2024-02-28 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | A - Grant | $31.18 | +10.6K | 41.1K | +35% | +$330.0K |
| 2024-02-06 | 2024-02-02 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | S - Sale | $31.89 | -1,637 | 30.5K | -5% | -$52.2K | |
| M | 2023-03-06 | 2023-03-02 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | A - Grant | $32.86 | +22.8K | 32.1K | +246% | +$750.0K |
| 2023-02-06 | 2023-02-02 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | S - Sale | $35.90 | -1,320 | 9,282 | -12% | -$47.4K | |
| 2022-02-03 | 2022-02-01 | SGRY | Surgery Partners, Inc. | Brittenham Marissa | Chief Strategy Off | A - Grant | $44.80 | +10.6K | 10.6K | New | +$475.0K |
Purchase Sale Sale after option exercise All abbreviations